Reims, France

Annie A Olivier

This inventor holds 4 USPTO granted patents. Top assignees: Ici Pharma, Imperial Chemical Industries Limited. Active years: 1985-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annie A Olivier. Retrieved from https://idiyas.com/inventor/annie-a-olivier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1985-1995

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Annie A Olivier

Introduction

Annie A Olivier is a notable inventor based in Reims, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin compounds. With a total of 4 patents to her name, her work has had a considerable impact on medical science.

Latest Patents

Among her latest innovations are the 3-heterocyclic thiomethyl cephalosporins. These compounds feature a 3-position substituent of the formula (I), which has been described in her recent patents. This advancement in cephalosporin compounds showcases her dedication to improving antibiotic treatments.

Career Highlights

Annie has worked with prominent companies in the pharmaceutical industry, including Ici Pharma and Imperial Chemical Industries Limited. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Throughout her career, Annie has collaborated with esteemed colleagues such as Frederic H Jung and Frank Loftus. These partnerships have fostered an environment of innovation and creativity, leading to the development of her notable patents.

Conclusion

Annie A Olivier's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her as a significant figure in medical research. Her work continues to influence the development of effective treatments in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…